In 1982 was created MRI Ventures, which is appeared as VC. The company was established in North America in United States. The main office of represented VC is situated in the Kansas City.
Among the most successful fund investment fields, there are Manufacturing, Homeland Security. Among the various public portfolio startups of the fund, we may underline Evogen For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are L Capital Partners.
The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2008. The fund is generally included in less than 2 deals every year.
Fund Name | Location |
AstraZeneca | Cambridge, Cambridgeshire, United Kingdom |
Brait | Central Region, Malta, NA - Malta |
Cook Pharmica, LLC | Bloomington, Indiana, United States |
Huaxing Alpha | New York, New York, United States |
Inmobiliaria e Inversiones el Coigue | Chile, Santiago Metropolitan Region, Vitacura |
Kenyan Cornerstone Group. | - |
McConnell Foundation | Canada, Montreal, Quebec |
Pearl Energy Investments | Dallas, Texas, United States |
Sumavision | Beijing, Beijing, China |
Yushan Ventures | Taipei, Taiwan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Evogen | $3M | 17 Nov 2008 | Kansas City, Missouri, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Evogen | $3M | 17 Nov 2008 | Kansas City, Missouri, United States |